These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8529319)
21. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M; Fait T; Kovar J; Poledne R; Ceska R Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [TBL] [Abstract][Full Text] [Related]
22. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA; Farias ML; Andrade AT Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087 [TBL] [Abstract][Full Text] [Related]
23. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women. Fak AS; Erenus M; Tezcan H; Caymaz O; Atagündüz P; Oktay S; Oktay A Eur Heart J; 2000 Feb; 21(3):190-7. PubMed ID: 10639300 [TBL] [Abstract][Full Text] [Related]
25. Isocaloric substitution of plant sterol-enriched fat spread for carbohydrate-rich foods in a low-fat, fibre-rich diet decreases plasma low-density lipoprotein cholesterol and increases high-density lipoprotein concentrations. Skeaff CM; Thoma C; Mann J; Chisholm A; Williams S; Richmond K Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):337-44. PubMed ID: 16216719 [TBL] [Abstract][Full Text] [Related]
26. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [TBL] [Abstract][Full Text] [Related]
27. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Hodson L; Skeaff CM; Chisholm WA Eur J Clin Nutr; 2001 Oct; 55(10):908-15. PubMed ID: 11593354 [TBL] [Abstract][Full Text] [Related]
28. Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia. Insull W; Davidson MH; Kulkarni PM; Siddhanti S; Ciaccia AV; Keech CA Metabolism; 2005 Jul; 54(7):939-46. PubMed ID: 15988705 [TBL] [Abstract][Full Text] [Related]
29. Influence of sport and low animal saturated fats intake diet on lipid dismetabolisms in postmenopausal women. Pafumi C; Ciotta L; Farina M; Maggi I; Intelisano G; Fiorito A; Chiarenza M; Cavallaro A; Pernicone A; Bosco P; Russo A; Bandiera S; Giardina P; Cianci A Minerva Ginecol; 2002 Jun; 54(3):279-85. PubMed ID: 12063444 [TBL] [Abstract][Full Text] [Related]
30. A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet. Morgan SA; O'Dea K; Sinclair AJ J Am Diet Assoc; 1997 Feb; 97(2):151-6. PubMed ID: 9020242 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J; Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189 [TBL] [Abstract][Full Text] [Related]
32. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Gylling H; Miettinen TA Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225 [TBL] [Abstract][Full Text] [Related]
33. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
34. Reduction of serum estradiol in postmenopausal women given free access to low-fat high-carbohydrate diet. Heber D; Ashley JM; Leaf DA; Barnard RJ Nutrition; 1991; 7(2):137-9; discussion 139-40. PubMed ID: 1666318 [TBL] [Abstract][Full Text] [Related]
35. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women. Denke MA Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139 [TBL] [Abstract][Full Text] [Related]
36. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women. Wolfe BM; Koval JJ; Nisker JA Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445 [TBL] [Abstract][Full Text] [Related]
37. Prolonged effects of a novel, low-dosage continuous progestin-cyclic estrogen replacement program in postmenopausal women. Plunkett ER; Wolfe BM Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):117-21. PubMed ID: 1733180 [TBL] [Abstract][Full Text] [Related]
38. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women. Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188 [TBL] [Abstract][Full Text] [Related]
39. Early effects of continuous low-dosage all-norgestrel administered alone or with estrogen. Wolfe BM; Plunkett ER Maturitas; 1994 Mar; 18(3):207-19. PubMed ID: 8015504 [TBL] [Abstract][Full Text] [Related]
40. [Dietary advice in hypercholesterolemia. Relation of selected dietary factors to total serum cholesterol and high density lipoprotein cholesterol]. Andersen MM; Ebbesen K; Hess K; Idorn ML; Simonÿ K Ugeskr Laeger; 1989 Aug; 151(35):2206-10. PubMed ID: 2781667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]